References
Fremstad, D. et al.: European Journal of Clinical Pharmacology 10: 441–444 (1976).
Goldbaum, L.R. and Smith, P.K.: Journal of Pharmacology and Experimental Therapeutics 111: 197–209 (1954).
Henry. J.A. and Mitchell, S.N.: British Journal of Clinical Pharmacology 11: 119P–120P (1981).
Henry, J.A. et al.: Journal of Pharmacy and Pharmacology 33: 179–182 (1981).
Kristensen, C.B. and Gram, L.F.: Acta Pharmacologica et Toxicologica 50: 130–136 (1982).
Nilsen, O.G.: Biochemical Pharmacology 25: 1007–1012 (1976).
Nilsen, O.G. and Jacobsen, S.: Biochemical Pharmacology 24: 995–998 (1975).
Pike, E. et al.: British Journal of Clinical Pharmacology (In press, 1983).
Sager, G. et al.: British Journal of Clinical Pharmacology 12: 613–620 (1981).
Storstein, L. and Janssen, H.: Clinical Pharmacology and Therapeutics 20: 15–23 (1976).
Wilting, J. et al.: Journal of Biological Chemistry 255: 3032–3037 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brørs, O., Nilsen, O.G., Sager, G. et al. Influence of pH and Buffer Type on Drug Binding in Human Serum. Clin Pharmacokinet 9 (Suppl 1), 85–86 (1984). https://doi.org/10.2165/00003088-198400091-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198400091-00012